NetworkNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Shareholders Approve Proposed Forward Stock Split

Health sciences company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) this morning announced that during its annual general and special meeting of shareholders on May 14, 2018, the proposed forward stock split of PreveCeutical’s issued and outstanding common shares on the basis of five new common shares for each one existing common share was approved by the company’s shareholders. Subject to approval by the Canadian Securities Exchange, the record date for the stock split will be May 24, 2018. On or about May 30, 2018, the company’s transfer agent will issue the additional number of common shares to shareholders of record as a result of the stock split. “We believe the stock split demonstrates the company’s continued commitment to broaden its shareholder base and we anticipate that the stock split will make PreveCeutical’s securities more accessible to investors and enhance liquidity for shareholders,” PreveCeutical CEO, president and chairman Stephen Van Deventer stated in the news release.

To view the full press release, visit http://nnw.fm/94qQ8

About PreveCeutical Medical Inc.

PreveCeutical is a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature identical products. PreveCeutical aims to be a leader in preventive health sciences and currently has five research and development programs, including: dual gene therapy for curative and prevention therapies for diabetes and obesity; the Program; Nature Identical peptides for treatment of various ailments; non-addictive analgesic peptides as a replacement to the highly addictive analgesics such as morphine, fentanyl and oxycodone; and a therapeutic product for treating athletes who suffer from concussions (mild traumatic brain injury). PreveCeutical sells CELLB9®, an Immune System Booster. CELLB9® is an oral solution containing polarized and potentiated essential minerals extracted from a novel peptide obtained from Caribbean Blue Scorpion venom. This product is available on the company’s website. For more information about PreveCeutical, please visit www.PreveCeutical.com

More from NetworkNewsBreaks

NetworkNewsBreaks – Hammer Fiber Optics Holdings Corp. (HMMR) and 1stPoint Communications Announce Launch of Mobile Network Services Provider Program NetworkNewsBreaks – Emmis Communications Corp. (NASDAQ: EMMS) Posts Fiscal Q4, Full-Year Financial Results NetworkNewsBreaks – EVIO, Inc. (EVIO) Posts Fiscal Q2 2018 Financial Results

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Latest News

The Latest: Zuckerberg to heading to EU next Tuesday

May 20, 2018

LONDON — The Latest on Facebook's privacy scandal (all times local): 1:40 p.m. Facebook CEO Mark Zuckerberg will meet with leaders of the European parliament in a closed-door meeting next Tuesday about the data protection scandal that has engulfed his company. Even though his visit had been announced, it was left unclear exactly when Zuckerberg would visit the European Union legislature. The EU and British parliaments have been calling for Zuckerberg to appear before them for weeks ever since it emerged that a company, political consultants Cambridge Analytica, had been allowed to misuse the data of millions of Facebook users....

European stocks higher as Brent crude breaches $80 a barrel

May 20, 2018

LONDON — European stocks brushed aside earlier losses in Asia to rise solidly Thursday with oil companies in demand as the international measure of oil struck its highest level in three-and-a-half years after French oil giant Total threatened to pull out of Iran. KEEPING SCORE: In Europe, Britain's FTSE 100 was up 0.3 percent to 7,754 while France's CAC 40 rose 0.5 percent to 5,592. Germany's DAX advanced 0.3 percent to 13,037. Futures augured a sluggish start on Wall Street. S&P futures dipped 0.1 percent while Dow futures remained flat. OIL: Benchmark U.S. crude oil rose 70 cents to $72.20...

European stocks take a breather after strong rally

May 20, 2018

LONDON — European stock markets eased slightly Friday after a strong rally saw many indexes strike multi-week highs. Wall Street was poised for further solid gains at the open despite ongoing geopolitical unease related to President Donald Trump's decision to pull the United States out of the Iran nuclear deal. KEEPING SCORE: In Europe, France's CAC 40 was down 0.3 percent at 5,520 while Germany's DAX also fell 0.3 percent to 12,986. The FTSE 100 index of leading British shares was 0.1 percent lower at 7,696. U.S. stocks are expected to open higher with Dow futures and the broader S&P...

Google suspends all ads related to Irish abortion referendum

May 20, 2018

LONDON — Google is suspending all advertising connected to Ireland's abortion referendum as part of moves to protect "election integrity," the company announced Wednesday. The move came a day after Facebook banned foreign-backed ads in the Irish campaign, amid global concerns about online election meddling and the role of internet ads in swaying voters. Google said that starting Thursday, it would no longer display ads related to the May 25 vote on whether to repeal Ireland's constitutional ban on most abortions. The prohibition on ads connected to the Irish vote applies to both Google and YouTube, which the company owns....

Hawking's family offers lottery for Westminster tickets

May 20, 2018

LONDON — The family of the late Stephen Hawking is holding a lottery to choose 1,000 people who will get a free ticket to attend a service of thanksgiving in the British physicist's honor at Westminster Abbey. Hawking's ashes are to be interred June 15 at the London church between the graves of Isaac Newton and Charles Darwin. The cosmologist's account of the mysteries of space, time and black holes in "A Brief History of Time" won him international acclaim. His work went on despite being diagnosed at age 21 with amyotrophic lateral sclerosis, or ALS. In a nod to...

Sign up now!